ERBB2 and neoplasm: Examining tumor samples by IHC, D1SP-treated tumors had lower percentages of Ki-67+ cells and less protein expression of p-ErbB3, p-ErbB2, and p-cMet compared with control tumors (Fig. 9K,L).